Abeona Therapeutics Inc. - Bathi resik saben siji saham sajrone rolas wulan pungkasan ABEO

This chart shows the market EPS (TTM) for Abeona Therapeutics (ABEO) at -173.20. Abeona Therapeutics (ABEO) develops advanced cell restoration methods for individuals with rare skin pathologies. The company attracts leading biologists through a system of long-term options and grants. The ability to exercise pricing power over therapy costs will emerge following FDA certification, which will secure a monopoly position for the business.
Abeona Therapeutics Inc. - rincian analitis lan metrik utama (ABEO)

When assessing the resilience of Abeona Therapeutics (ABEO) to external shocks, it is critical to consider its dependence on third-party CRO partners and cryogenic logistics. The annual growth rate of EPS (TTM) measures the pace of change in net income per share, reflecting the capitalization's reaction to borrowing costs. This indicator allows investors to promptly evaluate the business's ability to service debt outside of quarterly reports. The stability of this metric confirms the reliability of the operating model in a high-interest-rate environment.